Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion description "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion evidence source_evidence_literature NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion SIO_000772 22653055 NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion wasDerivedFrom befree-20140225 NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion wasGeneratedBy ECO_0000203 NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.